Virtual Biotech "Employs" 37,000 AI Agents for End-to-End Drug Development

Thousands of AI agents can efficiently analyze clinical and molecular data to identify drug targets. The computational approach has enabled researchers to build a virtual lab which supports end-to-end drug development.